Literature DB >> 27082951

Liver transplantation in Germany.

Frank Tacke1, Daniela C Kroy1, Ana Paula Barreiros2, Ulf P Neumann3.   

Abstract

Liver transplantation (LT) is a well-accepted procedure for end-stage liver disease in Germany. In 2015, 1489 patients were admitted to the waiting list (including 1308 new admissions), with the leading etiologies being fibrosis and cirrhosis (n = 349), alcoholic liver disease (n = 302), and hepatobiliary malignancies (n = 220). Organ allocation in Germany is regulated within the Eurotransplant system based on urgency as expressed by the Model for End-Stage Liver Disease score. In 2015, only 894 LTs (n = 48 from living donors) were performed at 23 German transplant centers, reflecting a shortage of organs. Several factors may contribute to the low number of organ donations. The German transplant legislation only accepts donation after brain death (not cardiac death), whereas advances in neurosurgery and a more frequently requested "palliative care" approach render fewer patients suitable as potential donors. The legislation further requires the active consent of the donor or first-degree relatives before donation. Ongoing debates within the German transplant field address the optimal management of patients with alcoholic liver cirrhosis, hepatocellular carcinoma (HCC), and cholangiocarcinoma and measures to increase living donor transplantations. As a result of irregularities at mainly 4 German transplant centers that were exposed in 2012, guiding principles updated by the German authorities have since implemented strict rules (including internal and external auditing, the 8-eyes principle, mandatory repeated testing for alcohol consumption) to prohibit any manipulations in organ allocation. In conclusion, we will summarize important aspects on the management of LT in Germany, discuss legal and organizational aspects, and highlight challenges mainly related to the relative lack of organ donations, increasing numbers of extended criteria donors, and the peculiarities of the recipient patients. Liver Transplantation 22 1136-1142 2016 AASLD.
© 2016 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27082951     DOI: 10.1002/lt.24461

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  22 in total

Review 1.  [Hepatic dysfunction in patients with cardiogenic shock].

Authors:  Philipp Kasper; Frank Tacke; Hans-Michael Steffen; Guido Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-09-19       Impact factor: 0.840

2.  Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections.

Authors:  Tansu Yamazhan; Cansu Bulut Avşar; Murat Zeytunlu; Meltem Taşbakan; Rüçhan Sertöz; Ayşın Zeytinoğlu; Şöhret Aydemir; Ömer Ünalp; Orkan Ergün; Alper Uğuz; Funda Özgenç; Fulya Günşar; İlker Turan; Sezgin Ulukaya; Nuri Deniz; Funda Yilmaz; Deniz Nart; Ezgi Güler; Kutsal Turhan; Zeki Karasu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

3.  [High donor age for liver transplantation : Tackling organ scarcity in Germany].

Authors:  S Moosburner; P V Ritschl; L Wiering; J M G V Gassner; R Öllinger; J Pratschke; I M Sauer; N Raschzok
Journal:  Chirurg       Date:  2019-09       Impact factor: 0.955

Review 4.  [Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver].

Authors:  M Schmelzle; F Krenzien; W Schöning; J Pratschke
Journal:  Chirurg       Date:  2018-11       Impact factor: 0.955

5.  Hospital Mortality and Current Trends in Liver Transplantation in Germany—a Systematic Analysis of Standardized Hospital Discharge Data, 2008–2017

Authors:  Sven H Loosen; Hans H Bock; Martin Hellmich; Wolfram T Knoefel; Christian Trautwein; Verena Keitel; Johannes G Bode; Ulf P Neumann; Tom Luedde
Journal:  Dtsch Arztebl Int       Date:  2021-07-26       Impact factor: 5.594

6.  Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities.

Authors:  Cyrill Wehling; Michael T Dill; Alexander Olkus; Christoph Springfeld; De-Hua Chang; Patrick Naumann; Thomas Longerich; Clemens Kratochwil; Arianeb Mehrabi; Uta Merle; Jan Pfeiffenberger; Christian Rupp; Karl Heinz Weiss; Markus Mieth
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-04       Impact factor: 4.553

Review 7.  The development and current status of Intensive Care Unit management of prospective organ donors.

Authors:  Margaret Kathleen Menzel Ellis; Mitchell Brett Sally; Darren Malinoski
Journal:  Indian J Urol       Date:  2016 Jul-Sep

8.  Distribution of Porcine Cytomegalovirus in Infected Donor Pigs and in Baboon Recipients of Pig Heart Transplantation.

Authors:  Uwe Fiebig; Jan-Michael Abicht; Tanja Mayr; Matthias Längin; Andrea Bähr; Sonja Guethoff; Almuth Falkenau; Eckhard Wolf; Bruno Reichart; Tomoyuki Shibahara; Joachim Denner
Journal:  Viruses       Date:  2018-02-06       Impact factor: 5.048

9.  Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis.

Authors:  Joanna Maria Lotowska; Maria Elzbieta Sobaniec-Lotowska; Dariusz Marek Lebensztejn; Urszula Daniluk; Piotr Sobaniec; Krzysztof Sendrowski; Jaroslaw Daniluk; Joanna Reszec; Wojciech Debek
Journal:  Gastroenterol Res Pract       Date:  2017-07-09       Impact factor: 2.260

10.  Kupffer cell depletion by gadolinium chloride aggravates liver injury after brain death in rats.

Authors:  Rongtao Zhu; Weizhi Guo; Hongbo Fang; Shengli Cao; Bing Yan; Sanyang Chen; Kaiming Zhang; Shuijun Zhang
Journal:  Mol Med Rep       Date:  2018-02-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.